Eli Lilly raises full-year revenue outlook on drug demand
Eli Lilly raised its full-year revenue outlook, citing stronger demand for obesity and diabetes drugs.
Related stories
South Korea Exchange Triggers KOSPI Trading Pause Mechanism
M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC
Intel shares plunge after hours on outlook miss
Intel shares fell in after-hours trading after its outlook came in below expectations.
M impact | EQUITY | Oct 30, 2026, 01:07 AM UTC
Korea Exchange Activates Circuit Breaker on KOSPI
The Korea Exchange activated a circuit breaker mechanism for the KOSPI.
M impact | EQUITY | Oct 30, 2026, 01:05 AM UTC
Korea Exchange Activates Sidecar on KOSPI
M impact | EQUITY | Oct 30, 2026, 01:05 AM UTC
Barramundi Limited reports annual shareholders’ meeting results
M impact | EQUITY | Oct 30, 2026, 01:04 AM UTC
Jupiter Mines Reports Q1 FY2027 Ore Sales of 848,566 Tonnes
M impact | EQUITY | Oct 30, 2026, 01:03 AM UTC